200004-39-3

Basic information

• Product Name: (R)-3-chloro-1-(4-fluorophenyl)propan-1-ol
• Synonyms: (R)-3-chloro-1-(4-fluorophenyl)propan-1-ol;(alphaR)-alpha-(2-Chloroethyl)-4-fluorobenzenemethanol
• CAS NO: 200004-39-3
• Molecular Formula: C₉H₁₀ClFO
• Molecular Weight: 188.6265032
• Mol File: 200004-39-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-3-chloro-1-(4-fluorophenyl)propan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-chloro-1-(4-fluorophenyl)propan-1-ol(200004-39-3)
• EPA Substance Registry System: (R)-3-chloro-1-(4-fluorophenyl)propan-1-ol(200004-39-3)

Safety Data

• Hazardous Substances Data: 200004-39-3(Hazardous Substances Data)

Usage

General Description

"(R)-3-chloro-1-(4-fluorophenyl)propan-1-ol" is a chemical compound with the molecular formula C9H10ClFO. It is a chiral compound with a specific configuration of atoms, denoted by the "R" designation in its name. (R)-3-chloro-1-(4-fluorophenyl)propan-1-ol contains a chloro substituent, a fluorophenyl group, and a hydroxyl group attached to a propan-1-ol moiety. It may be used as a building block in organic synthesis or as a reagent in chemical reactions. The specific arrangement of atoms in this compound gives it unique properties and potential applications in various fields of chemistry and industry.

Upstream product

• 31736-75-1 3-chloro-1-(4-fluorophenyl)propan-1-ol 
• 347-93-3 3-chloro-4'-fluoropropiophenone 
• 123-20-6 vinyl n-butyrate 
• 1345507-84-7 (R)-3-chloro-1-(4-fluorophenyl)propyl butyrate 

Downstream Products

• 926657-25-2 (R)-1-(4-Fluoro-phenyl)-3-iodo-propan-1-ol 

Relevant articles and documents

A method for preparing optically active 3-amino-1-phenylpropanol derivatives as an intermediate and a method for preparing optically active pharmaceutical products using the same

The present invention relates to a method for preparing a 3-amino-1-phenylpropanol derivative having (R) or (S) optical activity with 80% or more of an enantiomeric excess (ee), which includes a step of performing an asymmetric reduction reaction in the presence of a spiroborate ester catalyst and a hydrogen donor. The invention also relates to a method for preparing an optically active pharmaceutical product, which includes a step of preparing a (R)- or (S)-3-amino-1-phenylpropanol derivative, that is an intermediate, by using the catalyst.(AA) 3-amino-1-phenylpropanol(BB) Tomoxetine(CC) Nisoxetine(DD) FluoxetineCOPYRIGHT KIPO 2016

Ezetimibe analogs with a reorganized azetidinone ring: Design, synthesis, and evaluation of cholesterol absorption inhibitions

The underlying principle of drug design in this paper is that the maximum retention of the functional groups that exist in the marketed drug would provide a higher probability for comparable safety while the conformational changes in the newly created ana

Asymmetric Synthesis of 2-Aryl Substituted Oxetanes by Enantioselective Reduction of β-Halogenoketones using Lithium Borohydride modified with N,N'-Dibenzoylcystine

Optically active 2-aryl substituted oxetanes are synthesised in high enantiomeric excesses (up to 89percent e.e.) via enantioselective reduction of β-halogenoketones with lithium borohydride using (R,R')-N,N'-dibenzoylcystine and t-butyl alcohols as ligands.